FDA Approved: MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application to market Memantine and Donepezil Hydrochlorides Extended-Release from Amneal Pharmaceuticals NY LLC, for use in Alzheim…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine and Donepezil Hydrochlorides Extended-Release (memantine and donepezil hydrochloride extended-release)

Snippet

SUPPL AP for MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE (MEMANTINE AND DONEPEZIL)